Bloomberg's Krutoholow on Valeant, Halperin on Election (Audio)

of about point one percent. Down. Industrial is also down by point one percent, falling sixteen points to eighteen thousand, five hundred twelve. Naz Dak holding onto a game, up eight points to fifty two twenty one. If you're keeping track record on naz danc fifty two twenty eight point seventy one, a gain right now with two tens of one percent, ten year up fifteen thirty seconds, had healed one point five four percent, and gold hired by six forty the ounce of five tens of one percent to

thirteen forty two. I'm Charlie Pellett, and that's a Bloomberg Business flash. This is taking stock with pin Box and Kathleen Hayes on Bloomberg Radio. The shares of Valiant of Pharmaceuticals hired right Now by more than twenty percent, even though it posted a wider loss in its latest quarter. But the company says it's going to reorganize and continuing

to remake itself as a conventional pharmaceutical firm. Here to tell us more is Liz Kruda Hollow, Specialty Pharma and Biotech analyst for Bloomberg Intelligence, and you can follow Liz on Twitter at Liz Underscore Kruda Hollow. Liz, thanks very much for joining us. Tell us about Valiant Pharmaceuticals and why is the stock surging. Yeah, so most people were pretty happy to see that guidance have been maintained for

the year. We were expecting to see potentially some color around whether or not they expect that they could still meet their guidance on revenue and EPs and ITTA, which they do say that they can do, despite the fact that to did not look all that promising on those metrics. Now that they have to reaffirm their guidance in order to manage the debt covenants that they have with their lenders. Yeah,

so that's certainly part of it. So most of their debt covenants are tied to their EBITA ratios, and so that's something that we need to watch very carefully and make sure that they are maintained, otherwise the debt repayments

could accelerate. So one of the interesting things that came up in the fault today was they have divested several small assets, nothing too large, but they did indicate that they've received interest on what could potentially be a larger deal, and that could be something that would be about two billion dollars in revenue but could get them an additional

eight billion dollars for debt repayments. So that may be something that they look to to maintain that guidance, to make sure that they do actually meet the EBATA guidance and repay their debts for the year. The chief executive of Valiant, Joe Papa, is he going to remake this company me so that it looks nothing like the Valiant

of big acquisitions and big price increases. So that's the goal here and that's certainly what we would like to see on That's what most investors are really looking for a complete turnaround in strategy, as it's clear that the strategy of growing simply through M and A and price

increases really is no longer sustainable. So Papa comes from Parago, which is mostly age generic and consumer health company, so there are some synergies with the Valiant portfolio, and I think on the consumer health side he can do a really nice job with that. And he's done a pretty good job of leading a turnaround at Parago, So we're expecting that, you know, that's essentially why the board brought

him on to take over from Pearson. Now, another stock in the pharmaceutical industry that is surging today is Endo International shares. They are higher by more than twenty one percent right now. Tell us about Endo. So Endo is an interesting company. Day are sort of on the fence in terms of whether or not they are generics company or a specialty company. They're quite divided. However, they made an acquisition of par Pharmaceuticals last year in September that

puts them much more focused on the generic side. So basically in one queue we saw a huge impact on pricing and it was very detrimental to their earnings. They basically expect to see continuation of that erosion throughout the year. So we're expecting a bigger hit into q than we actually saw. So about some renewed enthusiasm there and that perhaps that one que was a one time effect and that it should moderate through the rest of the year.

The company is still guiding tours that by percent decline each quarter, so that's something we need to keep an eye on and make sure that people don't get a little too enthusiastic about the surprise in two Q. Thank you very much for spending time with us. Liz Kruda Hollow is our specialty format and biotech analysts for blue Berg Intelligence. Of course, Bloomberg Intelligence providing unique and real time research and context in a variety of industries as

well as markets and government factors that affect business. Our terminal customers can access this function at b I Go. We turn now to politics, and I'd like to bring in Mark Halpern. He is, of course the co author of the book Game Change and host of Bloomberg TVs with all due respect and it can be seen weekdays at five pm Eastern as well as week nights at five pm on Bloomberg in Washington, d C. Mark Halprin,

thank you very much for being here. Let's begin by just reviewing the speech that Donald Trump made yesterday at the Detroit Economic Club. What has been the reaction to his economic proposals? Very favorable reaction from the Wall Street Journal editorial page, which is a pretty good arbiter of where it sort its mainstream center right thinking is they criticize his Paul sees on trade, which they disagree with, but they liked much of the rest of what he did.

I don't think you saw very much what we call man by dog reaction, which is to say Democrats criticized the plan in seventeen different ways. I think Republicans were generally supportive, and a lot of Republicans pleased to see Trump talking about some of the orthodox positions the Republican Party, like tax cutting, less regulation, changing the Affordable Care Act. But some Republican senators not swayed by his speech on economics. Indeed, the GOP senator Susan Collins says she's not gonna be

supporting Donald Trump. Can we expect more of this pretty big defection? And I do think it will lead to more. You know, Donald Trump will say, and I think he's quite right that you'd rather have Republican voters than Republican politicians at a time when Washington and political figures are not in particularly high regard. At the same time, Susan

Collins is a very respected figure. She made her announcement that she wasn't going to vote for Trump in an opinion piece in The Washington Post in which he basically laid most of it off the questions about his temperament and judgment, particularly his conflict of recent conflict with the con Family. This is the exact argument that Hillary Clinton is making against Donald Trump is senator. Her argument is to have a respected figure in the Republican Party basically say,

I agree with Hillary Clinton. Donald Trump doesn't have the right temperament to be president. It's pretty damning thing. And I do think Trump will almost certainly see more defections and some perhaps is a direct result of what Susan Collins has done. Alright, Susan Collins a Republican Senator from Maine. Third party candidates Mark Halprin Uh, whether it is the Libertarian Party, the Green Party, or a new entrant an

independent candidate, Evan McMullen. It's going to be a guest on with all due respect today tell us about third party candidates, Well, it's very hard in this country that so favors the two major parties to break through at any level, particularly the presidential level, without fame and vast fortune or some pretty clear issue differences with the two

major party candidates. You've now got a Green candidate, a Libertarian Candida, and now this independent candidate or Republican who's running after a day and make it pretty clear that he's opposed to both Hillary Clinton and Donald Trump. I think the the issue for all of them is can they get that virtuous cycle going in politics? You want to raise money, have people here about your raising money?

Take you seriously. Your poll numbers go up, you get more media attention because people see the rising and the polls and raising money, and then off that media attention you raise more money and your poll numbers continue to go up. So can he get that virtuous cycle going? Can the Libertarians? Can the Green ideas matter? For sure?

And all three of the all three of those parties are have fielded candidates who are clearly are looking to expand their uh their reach based on ideas, But but they need money, they need access to the media, they need to have the polls go up, and obviously all three of them would like to see their poll numbers go up high enough that they can get into the

presidential debates. Does Evan McMullen have what it takes to get on the ballot in Utah to the point where he denies Donald Trump what has typically voted as a Republican state. Well, he's from Utah, he is a Mormon, and and and certainly as he looks at the states where he can do well, that'd be near at or near the top of the list. He says he's running to win and needs a lot more than just not just Utah, but perhaps other Western states with large Mormon populations.

And he does have to solve the puzzle of how to get on the ballot. Even in states where the deadlines haven't passed, it's still a difficult task to gather the signatures and fulfill the other requirements. So Utah is certainly in intriguing possibility, but it's not the only state

he plans to compete in. Just to pick up on what you just mentioned a moment ago about the presidential debates, what would it take for the libertarian candidate, let's say Gary Johnson or Green Party nominee Jill Stein, or indeed Evan McMullan to actually be at one of those lecterns in one of the three presidential debates, well the Commission Presidential Debates that said you need to be at fifteen percent in a series of national polls in order to qualify.

Donald Trump has said has said again as recently It's Today to Time Magazine, that he wants to say in some of the dimensions of this of how the debates work, the anothering magic about the fifteen percent threshold. Trump has also said that he'd like one on one with Hillary Clint.

He doesn't want other candidates on the stage, and I suspect that he will try to use his leverage, uh to extent he has any to make sure that other candidates aren't on the stage, assuming that he really does want that one on one that he says he does, if one of those third part of candidates does get on the stage, who does that help? Who does that hurt? Now? I've asked a lot of my best sources about that, and there's mixed feelings about it. I don't think there's

any clear answer to it at this point. My guess is Trump probably is right that he's better off one on one simply because as he's behind and he needs to try to kind of get a clean shot at the person who's ahead of him. Now, thank you very much. Mark Halpern. He is, of course, co host of With All Due Respect, co managing editor of Bloomberg Politics, With all due Respect, weeknights five pm on Bloomberg Television and Bloomberg One in Washington, d C. This is Bloomberg